Member Info for ZzTop1

And we all believe you. Call your broker.

Doubt it Wiggly but that £1.80 sell by AS is looking very good now. He's known about the saliva test progress for some time now so questions really do need to be asked.

Can Al be trusted? Sadly I now have "significant" doubts as the sp declines "quickly".

Poundcake, give it a rest please. Are you on speed or something? Ramping the crap outta this constantly helps none of us

I doubt any one of you or us will be here when or if this happens. But otherwise a very good discussion point

I'm convinced there'll be an RNS in the next 3 working days which will update on Bams and lft.

We've had a decent rise this week but knowing how this sp moves, I think we could also see a decent rise Monday and Tuesday next week. Just a hunch

Amen!

Ramp my brother, ramp it good!!!

A proud moment for mofofreeman, sharing something of use for a change. Like.

Thanks mofo!

Ask him what MOFO means

When are we going to get news on a vaccine not being quite as good as the last one.

I'm pretty sure the Russian one will be 117% effective in 99 year olds

Thanks Sujood for enlightening us. I'll sleep well tonight now

For confirmation, Bams will be for hospitals, to my info superlabs not looking at MS right now.

Ban MOFOfreeman he spends way too much time on this board and adds ZERO value

I understand the concern, Foreverwaiting. It's a simple play however: We've been told that there's enough room for all rapid tests and we also know that the tt will be done this year along with at least the start of the validation. Now you either believe that or you don't. In or out. Simple. If you don't like the risk, it's easier to go buy hsbc or iag and try and make back any losses

For one it shows that the need for increased testing continues to grow well into next year despite vaccine news. Secondly what you mean by rapid is what? 1 day? Does not compare to 10 minutes. With the right test, Moonshot can and will work. Foreverwaiting, are you suggesting that the govt would just ignore such a test?

The amount being invested in test & trace lighthouse mega labs which are due to open and build out through Q1 next year is massive.

Gives me increased confidence that any gold standard rapid saliva test will also be massive.

Yes too cynical. Avacta is a biotech with multiple platforms. Diagnostics and therapeutics. Success in one will support the other.

- Expected demand for a few years
- Key challenge is being able to manufactures enough tests
- Based on Elisa, the test should be gold standard
- Talking to more manufacturing partners including in Asia
- Significant commercial progress
- Gold standard Bams

... And the list goes on. Now if you was Al, would you really say all of this stuff and then fail to deliver? No chance!

So does this mean we should be back to around 160p tomorrow??

The Avacta story will unfold over the next 5 years or so. This is another point in time. Miss this massive Covid opportunity and the story will carry on regardless. Get it right and Avacta will open up new revenue streams. Yes Al knows exactly what is at stake but he will have a plan either way.

Sorry to sound negative, it's important we remain balanced in our views. Go back through RNS's for the last 5 years and you'll see Avacta have been at "inflection" points before. The difference for me this time around is yes Avacta has been ramped up good and proper and if Al misses the boat here then he will never be trusted again. He should be worried about his integrity just as much as missing out on the "game changer"

Better than charts, start following the brokers. Zeus Never Lose should be the new company strap line...

Charts are OK in my views. Candle charts have been about 60-70% accurate on Avacta over the last 6 months. I use them but only for reference.